Life sciences news
-
Galapagos completes patient recruitment for MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
Tuesday November 23rd 2021
Read more
-
OXURION NV secures EUR 10 million convertible bond financing from Kreos Capital and Pontifax Ventures
Monday November 22nd 2021
Read more
-
P95 appoints Henk Hoornaert as Chief Commercial Officer
Wednesday November 17th 2021
Read more
-
New study demonstrates Idylla™ EGFR Mutation Test (CE-IVD) shortens time to patient management decisions for patients with non-small cell lung cancer
Tuesday November 16th 2021
Read more
-
Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis
Monday November 15th 2021
Read more
-
Biotalys’ first biocontrol Evoca™ demonstrated to be excellent new tool for growers in 2021 independent field trials
Monday November 15th 2021
Read more
-
OXURION NV - First patient dosed in Part B of Phase 2 KALAHARI study evaluating multiple administrations of THR-149 versus aflibercept for treatment of Diabetic Macular Edema (DME)
Monday November 15th 2021
Read more
-
Belgium has all the ingredients to be a top country for data science in health – but we have to act now!
Monday November 15th 2021
Read more
-
Become a flanders.bio member
Your news here?
-
GSK and imec to collaborate on disruptive innovation in pharma
Tuesday November 9th 2021
Read more
-
reMYND and the US NINDS Epilepsy Therapy Screening Program (ETSP) begin collaboration on epilepsy program
Monday November 8th 2021
Read more
-
Agomab Therapeutics to acquire Origo Biopharma
Thursday October 28th 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
